| | ASRM: Femhrt And Estrostep (Norethindrone Acetate/Ethinyl Estradiol) Combat Osteoporosis And Acne (Site not responding. Last check: 2007-09-15) |
 | | Continuous-combined hormone replacement therapy (CCHRT), femhrt® (norethindrone acetate/ethinyl estradiol tablets), and Estrostep® (norethindrone acetate/ethinyl estradiol tablets), an estrophasic oral contraceptive (birth control pill), have proven successful in offering women additional benefits in preventing osteoporosis and treating moderate acne vulgaris, respectively. |
 | | Continuous-combined hormone replacement therapy, femhrt, contains a combination of two hormones in a single tablet, an estrogen called ethinyl estradiol (EE) and a progestin called norethindrone acetate (NA), and is proven to relieve the vasomotor symptoms of menopause and to prevent osteoporosis. |
 | | Progestogens/estrogens should not be used in individuals with any of the following conditions or circumstances: sensitivity to these components; known or suspected pregnancy, breast cancer or estrogen-dependent neoplasia; undiagnosed abnormal genital bleeding; active or past history of thrombophlebitis or thromboembolic disorders. |
| www.pslgroup.com /dg/20B7DE.htm (1034 words) |